- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05444023
Comparison of Suturing Technique Types on Pubocervical Fascia at Colpographhy Anterior for Cystocele Repair
Comparison of Suturing Technique Types on Pubocervical Fascia at Colporrhaphy Anterior for Cystocele Repair
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary and secondary endpoints:
Primary outcome measures will be the subjective cure of prolapse ("absence or presence of a bulge in the vagina"), objective success with anatomic absence of advanced prolapse at POP-Q sites Ba, C and Bp defined as less than 1 cm individually and as a total.
Secondary outcome measures include all other parameters such as perioperative outcomes, patient satisfaction, quality of life outcomes, complications, scores on questionnaires, and reoperations.
The study protocol will be submitted to the institutional review boards of every participating study site and written informed consent will be obtained from all participants on enrolment.
Project design: The investigators will perform an international singlecentre single-blind randomized controlled trial by participating in our tertiary referral hospital.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Kanuni Sultan Suleyman Training and Research Hospital
-
İstanbul, Turkey, 34307
- Kanuni Sultan Suleyman Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women with symptomatic stage 2 or greater (point C -1 or more pelvic organ prolapse quantification POP-Q) cystocele
- Women aged between 18-75 years of age
Exclusion Criteria:
- Women not eligible for surgery for medical or anesthesiological reasons
- Inability to comprehend questionnaires
- Inability to give informed consent
- Inability to return for a review
- Prior anterior compartment repair with or without mesh
- Severe cardiovascular or respiratory disease
- Women who don't want anterior compartment repair
- Pregnancy
- Age <18 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Transverse separated suturing technique
During pubocervical fascia reconstruction, the surgeon will perform suturing at the transverse plane with an intermittent stitching technique.
|
Suturing type techniques on pubocervical fascia reconstruction at anterior compartment defects.
|
|
Active Comparator: circular continue suturing technique
During pubocervical fascia reconstruction, the surgeon will perform a continuous stitching technique which includes the lateral parts of the anterior compartment defect.
|
Suturing type techniques on pubocervical fascia reconstruction at anterior compartment defects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective cure rate of prolapse
Time Frame: Time Frame: 12 months after intervention
|
Provided by the patient's feeling of the "Absence of a bulge in the vagina"
|
Time Frame: 12 months after intervention
|
|
Objective success
Time Frame: Time Frame: 12 months after intervention
|
Defined as anatomic absence of advanced prolapse at POP-Q sites Ba, C and Bp defined as less than 1 cm individually and as a total
|
Time Frame: 12 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prolapse-related Quality of life
Time Frame: Time Frame: 12 months after intervention
|
This will be assessed using a validated questionnaire (Prolapse Quality of Life questionnaire P-QoL) The questionnaire contains 9 domains. Each answer of the patient will have values that range between 1 to 4 or 1 to 5 for the 1st question only). (1 very good 4/5 very poor). There is no overall score. A symptomatic woman might have only one domain impaired and another one might have all domains impaired. We consider both of them symptomatic but in different or same aspects of quality of life. To differentiate different domains, it is important for the decision of our surgery (we will be careful in shortening and narrowing a vagina of a woman who had only a preoperative high (impaired) Personal relationships domain score and other domains in the normal range). This will also help us in the follow up visits. |
Time Frame: 12 months after intervention
|
|
Failure (%)
Time Frame: Time Frame: 12 months after intervention
|
Recurrence rate
|
Time Frame: 12 months after intervention
|
|
Complications
Time Frame: Time Frame: 12 months after intervention
|
İnjury ( bowel, intestinal, blood vessel injuries)
|
Time Frame: 12 months after intervention
|
|
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)
Time Frame: Time Frame: 12 months after intervention
|
The PISQ-12 is a self-adminestered questionnaire that evaluates sexual function of women with pelvic organ prolapse or urinary incontinence.
The questionnaire has 12 items.
Other than the first 4 questions that are scored from 4 to 0, all questions are scored from 0 to 4. The total score is calculated with totaling the score of each question.
The maximum score is 48.
Higher scores show good sexual functioning of women.
|
Time Frame: 12 months after intervention
|
|
Incontinence Impact Questionnaire (IIQ-7)
Time Frame: Time Frame: 12 months after intervention
|
evaluating the impact of urinary incontinence
|
Time Frame: 12 months after intervention
|
|
Pelvic Floor Distress Inventory (PFDI - 20)
Time Frame: Time Frame: 12 months after intervention
|
evaluating the bowel, bladder, or pelvic symptoms
|
Time Frame: 12 months after intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KanuniSSEAH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.